Despite six decades of efforts to synthesize peptides and proteins bearing multiple disulfide bonds, this synthetic challenge remains an unsolved problem in most targets (e.g., knotted mini proteins). Here we show a de novo general synthetic strategy for the ultrafast, highyielding formation of two and three disulfide bonds in peptides and proteins. We develop an approach based on the combination of a small molecule, ultraviolet-light, and palladium for chemo- and regio-selective activation of cysteine, which enables the one-pot formation of multiple disulfide bonds in various peptides and proteins. We prepare bioactive targets of high therapeutic potential, including conotoxin, RANTES, EETI-II, and plectasin peptides and the linaclotide dr...
Disulfide-rich cyclic peptides have exciting potential as leads or frameworks in drug discovery; how...
A new strategy was developed for the synthesis of peptide disulfide-bond mimics using fully orthogon...
A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and...
Structure-activity relationship studies are a highly time-consuming aspect of peptide-based drug dev...
Disulfide bonds are an important structural feature in many peptides. Controlled disulfide bond form...
Cysteine (Cys) is a unique amino acid due to its ability to form reversible covalent disulfide bonds...
The application of chemical methods to biological systems has led to great advances in all life scie...
The site-selective modification of peptides and proteins facilitates the preparation of targeted the...
The introduction of non-natural entities into proteins by chemical modification has numerous applica...
Existing disulfide-rich peptides, both naturally occurring and de novo designed, only represent a ti...
Precise disulfide pairing in synthetic peptides usually is achieved using orthogonal protecting grou...
Disulfide-rich cyclic peptides have exciting potential as leads or frameworks in drug discovery; how...
In regard to polypeptides, cysteine residues are composed of a sidechain group containing a thiol gr...
ABSTRACT: The introduction of non-natural entities into proteins by chemical modification has numero...
Methodologies to conjugate proteins to property-enhancing entities are highly sought after. We repor...
Disulfide-rich cyclic peptides have exciting potential as leads or frameworks in drug discovery; how...
A new strategy was developed for the synthesis of peptide disulfide-bond mimics using fully orthogon...
A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and...
Structure-activity relationship studies are a highly time-consuming aspect of peptide-based drug dev...
Disulfide bonds are an important structural feature in many peptides. Controlled disulfide bond form...
Cysteine (Cys) is a unique amino acid due to its ability to form reversible covalent disulfide bonds...
The application of chemical methods to biological systems has led to great advances in all life scie...
The site-selective modification of peptides and proteins facilitates the preparation of targeted the...
The introduction of non-natural entities into proteins by chemical modification has numerous applica...
Existing disulfide-rich peptides, both naturally occurring and de novo designed, only represent a ti...
Precise disulfide pairing in synthetic peptides usually is achieved using orthogonal protecting grou...
Disulfide-rich cyclic peptides have exciting potential as leads or frameworks in drug discovery; how...
In regard to polypeptides, cysteine residues are composed of a sidechain group containing a thiol gr...
ABSTRACT: The introduction of non-natural entities into proteins by chemical modification has numero...
Methodologies to conjugate proteins to property-enhancing entities are highly sought after. We repor...
Disulfide-rich cyclic peptides have exciting potential as leads or frameworks in drug discovery; how...
A new strategy was developed for the synthesis of peptide disulfide-bond mimics using fully orthogon...
A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and...